Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May inform remnant lipoprotein assessment in hyperlipidemia; leaves open targeted intervention trials.
Improved methods for quantification of organ-specific contributions to postprandial hyperlipidemia indicate substantial increases in the concentration and altered properties of hepatogenous VLDL, in addition to accumulation of chylomicron remnants. Recent clinical studies support the hypothesis that small chylomicron remnants characterized by apolipoprotein (apo)B48 and VLDL remnants characterized by apolipoprotein B100 are atherogenic lipoproteins.
No takes yet. Share an insight, caveat, or question.
Richard J. Havel (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: